YANGZHOU, China, Feb. 8, 2023
/PRNewswire/ -- Meihua International Medical Technologies Co., Ltd.
("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer
and provider of Class I, II and III disposable medical devices with
operating subsidiaries in China,
today announced the Company will seek to explore the application of
ChatGPT technologies to develop online health consultation services
and is now actively laying out the research and development of
related facilities application and technology platforms.
In recent years the Company has been continuously exploring the
application of intelligent content and data generation technologies
to help accelerate the development of online AI health consultation
services that often involves collection and analysis of
unstructured texts.
MHUA will seek to cooperate with research centers in the field
and conduct in-depth analysis on the possible application and
expansion of ChatGPT related technologies in the Company's
endeavors to develop its online AI health consultation
services.
ChatGPT technologies enable reading and analysis of vast volumes
of text and data and is capable of generating sentences that are
similar to how humans talk and write, including finding patterns in
a dataset without being given labeled examples or explicit
instructions about what to look for. The technologies are designed
to digest content from across the web, which means users are likely
to receive more relevant and well-informed answers.
The Company believes ChatGPT technologies have great potential
for use in assisting online health consultation that involves
answering questions concerning basic health care issues which would
not necessarily require an in person visit. Further, such
technology could potentially help push automated health
consultation services to a new level of sophistication, producing
relevant answers so users are not left waiting to speak to a doctor
or nurse practitioner, which could potentially help reduce wait
times while providing informed answers to more basic health-related
inquiries.
Mr. Xin Wang, CEO of the Company,
commented: "ChatGPT is one of the fastest adopted AI tools in
history. It is incredibly useful for general research purposes, but
not yet widely utilized at handling complex life science texts and
data. We are seeking to work with industry experts to try to
explore the potential of ChatGPT technologies to assist MHUA's
R&D capabilities and its efforts to develop our online health
consultation platform, which could have the potential to create
virtual assistants to provide personalized recommendations and
advice to patients based on their medical history, current
symptoms, and other relevant factors."
About Meihua International Medical Technologies Co.,
Ltd.
Meihua International Medical Technologies is a reputable
manufacturer and provider of Class I, II, and III disposable
medical devices with operating subsidiaries in China. The Company manufactures and sells
Class I disposable medical devices, such as eye drop bottles,
medicine bottles and anal bags, and Class II and III disposable
medical devices, such as identification tape, gynecological
examination kits, inspection kits, surgical kits, medical brushes,
medical dressing, masks, disposable infusion pumps, electronic
pumps and puncture kits, which products are sold under its own
brands and also sourced and distributed from other manufacturers.
The Company has received international "CE" certification and ISO
13485 system certification and has also registered with the FDA
(registration number: 3006554788) for more than 20 products. The
Company has served hospitals, pharmacies, medical institutions and
medical equipment companies for over 30 years, providing more than
800 types of products for domestic sales, as well as 120 products
which are exported to more than 30 countries internationally across
Europe, North America, South
America, Asia, Africa and Oceania. For more information,
please visit www.meihuamed.com.
Forward-Looking Statements
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies, the Company's future
business development and plans of future business development,
financial conditions and results of operations, product and service
demand and acceptance, reputation and brand, the impact of
competition and pricing, changes in technology, government
regulations, fluctuations in general economic and business
conditions in China, and
assumptions underlying or related to any of the foregoing and other
risks contained in reports filed by the Company with the U.S.
Securities and Exchange Commission ("SEC"). For these reasons,
among others, investors are cautioned not to place undue reliance
upon any forward-looking statements in this press release.
Additional factors are discussed in the Company's filings with the
SEC, which are available for review at www.sec.gov. The Company
undertakes no obligation to publicly revise these forward-looking
statements to reflect events or circumstances that arise after the
date hereof.
For more information, please contact:
Janice Wang
Wealth Financial Services LLC
Phone:
+86 13811768599
+1 628 283 9214
Email: services@wealthfsllc.com
View original
content:https://www.prnewswire.com/news-releases/meihua-international-medical-technologies-co-explores-application-of-chatgpt-technologies-to-develop-online-ai-health-consultation-services-301741608.html
SOURCE Meihua International Medical Technologies Co., Ltd.
